Past & current projects
On this page
Horizon Europe
Digital Europe
Go back to parent page
Our services
Are you looking for some inspiration? Nothing better than to have a look at past and ongoing projects

Horizon Europe

  • The Horizon results platform focuses on the results of funded projects.
  • The Community Research and Development Information Service (CORDIS) has a projects and results database which can be browsed on all funded projects from the first framework programme until today. Furthermore it offers results packs which report on collections of results of different projects focusing on a specific theme.
  • All funded Horizon projects have websites at least for the duration of the projects, on which many information is given on the projects work packages, tasks and outcomes
  • A database is available of  success stories  of projects  under Horizon Europe’s successors
  • Several of our (sub)programme pages on the NCP Flanders website link to programme specific project databases (related links)
  • The Horizon Results Booster offers free of charge support services to boost the exploitation potential of your research results, disseminate effectively, and go to market

Digital Europe

  • The Project & Results page on the Funding & Tenders Portal offers an overview of all projects under Digital Europe.
  • Digital Europe projects have websites at least for the duration of the projects, on which many information is given on the projects work packages, tasks and outcomes.
 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of FWO
Logo of VLAIO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn